Hu and Voltage-Gated Calcium Channel (VGCC) Antibodies Related to the Prognosis of Small-Cell Lung Cancer

Sissel E. Monstad, L. Drivsholm, Anette Storstein, +5

Journal of Clinical Oncology

Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis

Manja Schubert, Debabrata Panja, Mette Haugen, +2

Acta Neuropathologica

CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration

Torbjørn Kråkenes, Ida Herdlevær, Margrethe Raspotnig, +3

Annals of Neurology

Pcd PatientsAmyotrophic Lateral SclerosisCdr2l AntibodiesImmunotherapyMedicine +13

CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration

Tilo Wolf Eichler, Cecilie Totland, Mette Haugen, +5

PLoS ONE

Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies

Margrethe Raspotnig, Mette Haugen, Maria Thorsteinsdottir, +4

Cancer Immunology Immunotherapy

Malignant DiseaseYo AntibodiesPathologyDegenerative DiseaseMedicine +3

Onconeural antibodies: Improved detection and clinical correlations

Anette Storstein, Sissel E. Monstad, Mette Haugen, +5

Journal of Neuroimmunology

Onconeural AntibodiesMedicineHistopathologyDiagnosisImmunology +7

CDR2 antigen and Yo antibodies

Cecilie Totland, Nina Karin Aarskog, Tilo Wolf Eichler, +7

Cancer Immunology Immunotherapy

Paraneoplastic Cerebellar Degeneration

Ida Herdlevær, Mette Haugen, Kibret Mazengia, +2

Neurology Neuroimmunology & Neuroinflammation

Room-Scale CO2 Injections in a Physical Reservoir Model with Faults

Martin A. Fernø, Mette Haugen, Kristoffer Eikehaug, +7

Transport in Porous Media

EngineeringEarth ScienceReservoir EngineeringPetroleum ReservoirSubsurface Energy Storage +19

Progressive striatal necrosis associated with anti-NMDA receptor antibodies

Charalampos Tzoulis, Christian A. Vedeler, Mette Haugen, +6

BMC Neurology